Stay updated on CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC
Sign up to get notified when there's something new on the CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC page.

Latest updates to the CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check31 days agoChange DetectedThe page has updated the study title from 'CK-301' to 'CONTERNO' and changed the status from 'Results Submitted' to 'Results Posted', indicating a significant progression in the study's timeline.SummaryDifference3%
- Check67 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check81 days agoChange DetectedThe page has been updated to indicate that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.5%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC
Enter your email address, and we'll notify you when there's something new on the CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC page.